Pathophysiology of Hypocalcemia in Vitamin D Deficiency
Vitamin D deficiency causes hypocalcemia through two primary mechanisms: reduced intestinal calcium absorption and impaired suppression of parathyroid hormone (PTH) gene expression, leading to secondary hyperparathyroidism that mobilizes calcium from bone to maintain serum levels.
Primary Mechanisms
Reduced Intestinal Calcium Absorption
Vitamin D deficiency directly impairs the efficiency of intestinal calcium absorption 1, 2. When 25-hydroxyvitamin D [25(OH)D] levels fall below adequate thresholds, the kidney's ability to generate calcitriol [1,25(OH)₂D₃] is compromised 1. Since calcitriol is responsible for increasing gut absorption of dietary calcium 3, its deficiency results in decreased calcium uptake from the gastrointestinal tract, creating negative calcium balance.
Impaired PTH Regulation
The second mechanism involves disruption of parathyroid gland function. Reduced plasma levels of 1,25(OH)₂D lead to impaired suppression of the parathyroid gene that initiates PTH synthesis 1. This results in secondary hyperparathyroidism as a compensatory response to maintain serum calcium levels.
The Compensatory Cascade
Secondary hyperparathyroidism maintains serum calcium in the normal range initially, but at significant skeletal cost 2. The elevated PTH:
- Mobilizes calcium from bone through increased osteoclastic activity, creating local foci of bone weakness and generalized decreased bone mineral density
- Increases phosphorus wasting in the kidneys through phosphaturia, resulting in low-normal or low serum phosphorus levels 2
- Creates inadequate calcium-phosphorus product, causing mineralization defects in the skeleton
Clinical Manifestations by Age
In children, the mineralization defect manifests as rickets with skeletal deformities, since they have little mineral reserve in their skeleton 2.
In adults, with closed epiphyseal plates and more skeletal mineral, the defect presents as osteomalacia—often going undetected but causing decreased bone mineral density and generalized bone and muscle pain 2.
When Compensation Fails
Severe vitamin D deficiency (25(OH)D levels ≤5 ng/mL or 12 nmol/L) can result in frank hypocalcemia 1, as the compensatory mechanisms become insufficient. At this point, hypocalcemia exacerbates mineralization defects and accelerates osteomalacia development 4.
The presence of hypocalcemia in the setting of vitamin D deficiency represents a failure of the PTH-mediated compensatory response to maintain adequate serum calcium levels despite maximal bone resorption and renal calcium conservation 4.
Key Pathophysiologic Points
- Vitamin D insufficiency (25(OH)D levels below 30 ng/mL or 75 nmol/L) is associated with elevated PTH levels even before frank hypocalcemia develops 1
- The correlation between 25(OH)D and 1,25(OH)₂D levels is significant (r = 0.5145, P < 0.001), demonstrating that substrate availability directly impacts active vitamin D production 1
- Inappropriately low or low-normal PTH in the setting of hypocalcemia and vitamin D deficiency suggests functional hypoparathyroidism, which can occur in severe cases 5
Clinical Significance
This pathophysiology explains why vitamin D deficiency causes a spectrum of presentations—from asymptomatic biochemical abnormalities (elevated PTH with normal calcium) to symptomatic hypocalcemia with tetany, seizures, and cardiac arrhythmias in severe cases 6, 7. The degree of hypocalcemia depends on the severity and duration of vitamin D deficiency, the adequacy of dietary calcium intake, and the parathyroid glands' ability to mount an appropriate compensatory response.